Scandinavian Astor Group (ASTOR) Q2 2025 earnings summary
Event summary combining transcript, slides, and related documents.
Q2 2025 earnings summary
24 Nov, 2025Executive summary
Net sales grew 77% year-over-year in Q2 2025, with 33% organic growth and strong order intake up 85%.
Pro forma 2024 net sales expected at SEK 460 million, with significant M&A activity and investment capacity exceeding SEK 450 million.
Market cap stands at approximately SEK 2 billion, with operations in four countries and around 200 employees, not including recent acquisitions.
Major acquisitions and investments included Carbonia Composites, Nordic Shield Group, and Ammunity SIA, expanding presence in defense and composites.
Order book at quarter-end was SEK 289 million, rising to SEK 374 million after July orders.
Financial highlights
Q2 2025 net sales: SEK 90.6 million (Q2 2024: SEK 51.2 million); H1 2025 net sales: SEK 165.3 million (H1 2024: SEK 87.6 million).
EBITDA and adjusted EBITDA rose by several hundred percent compared to the same period last year.
Q2 EBITDA: SEK 8.9 million; adjusted EBITDA: SEK 10.9 million; rolling 12-month adjusted EBITDA margin at 14.6%.
Third consecutive quarter of bottom-line profitability.
Cash flow from operations in Q2: SEK 6.9 million; H1: SEK 13.4 million.
Outlook and guidance
Financial targets for 2028: sales of at least SEK 2,500 million and EBITDA margin of at least 15%.
Strong second half of the year anticipated, with full effects from recent acquisitions and new product deliveries expected from July.
Ongoing transition to a regulated market listing expected by year-end 2025, with most costs already incurred.
Ocellium Electronic Warfare expected to contribute regularly starting Q3.
Full effect from 30% stake in Nordic Shield Group and 100% acquisition of Carbonia to be realized from July 2025.
Latest events from Scandinavian Astor Group
- Net sales hit SEK 433M in 2025, EBITDA surged, and the order book reached SEK 420M.ASTOR
Q4 202518 Feb 2026 - SEK 150 million raised, SEK 2.5bn 2028 target set, with strong growth and M&A focus.ASTOR
Investor Update26 Dec 2025 - Record 2024 sales, strong order book, and acquisitions drive momentum for future growth.ASTOR
Q4 20243 Dec 2025 - Q1 2025 sales doubled, EBITDA margin exceeded 10%, and M&A activity accelerated.ASTOR
Q1 202526 Nov 2025 - Record sales, EBITDA, and order intake in Q3, fueled by acquisitions and organic growth.ASTOR
Q3 202512 Nov 2025 - Q3 sales surged 91% year-over-year, with a record order book and strong outlook for Q4.ASTOR
Q3 202413 Jun 2025 - Q2 sales up 131% with record order book and positive EBITDA, supporting strong growth.ASTOR
Q2 202413 Jun 2025